GlaxoSmithKline S.A.E Market Cap

GlaxoSmithKline S.A.E has a market cap or net worth of 3.17 billion as of May 13, 2025. Its market cap has increased by 26.44% in one year.

Market Cap

3.17B

Enterprise Value

3.22B

Revenue

2.99B

Ranking

n/a

PE Ratio

18.23

Stock Price

37.97

Market Cap Chart

Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 3.17B, an increase of 456.86%. That is a compound annual growth rate of 9.09%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	3.17B	5.47%
Dec 31, 2024	3.01B	1.27%
Dec 31, 2023	2.97B	-6.84%
Dec 29, 2022	3.19B	23.58%
Dec 30, 2021	2.58B	82.08%
Dec 31, 2020	1.42B	-14.17%
Dec 31, 2019	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Commercial International Bank Egypt (CIB) S.A.E.	243.00B
El Sewedy Electric Company	172.09B
Talaat Moustafa Group Holding	110.61B
Eastern Company S.A.E	104.04B
Misr Fertilizer Production Company	81.92B
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.)	67.38B
Egypt Aluminum	66.41B
Alexandria Container&Cargo Handling Company	65.73B

Market Cap Rankings